Screening adults for pre-diabetes and diabetes may be cost-saving.

ABSTRACT:

Objective

The economic costs of hyperglycemia are substantial. Early detection would allow management to prevent or delay development of diabetes and diabetes-related complications. We investigated the economic justification for screening for pre-diabetes/diabetes.

Research design and methods

We projected health system and societal costs over 3 years for 1,259 adults, comparing costs associated with five opportunistic screening tests. All subjects had measurements taken of random plasma and capillary glucose (RPG and RCG), A1C, and plasma and capillary glucose 1 h after a 50 g oral glucose challenge test without prior fasting (GCT-pl and GCT-cap), and a subsequent diagnostic 75 g oral glucose tolerance test (OGTT).

Results

Assuming 70% specificity screening cutoffs, M

SUBMITTER: Chatterjee R 

PROVIDER: S-EPMC2890345 | biostudies-literature | 2010 Jul

REPOSITORIES: biostudies-literature